Perceptive Capital Solutions Corp (PCSC) is a special purpose acquisition company in the Financial Services sector, listed on The Nasdaq Global Market under the ticker PCSC. It is described as a blank check company formed for the purpose of entering into a combination with one or more businesses or entities, with an intended focus on healthcare in the United States and other developed countries.
This SEC filings page is designed to help users review the regulatory record associated with PCSC’s SPAC activities. Although specific filings are not listed in the provided data, public communications indicate that PCSC’s securities were registered with the U.S. Securities and Exchange Commission in connection with its initial public offering of Class A ordinary shares. The registration statement for that offering was declared effective by the SEC, and the company notes that the offering was made only by means of a prospectus filed with the Commission.
In connection with its announced business combination with Freenome Holdings, Inc., PCSC has stated that it intends to file a registration statement on Form S-4 with the SEC. That filing is expected to include preliminary and definitive proxy statements for PCSC shareholders and a prospectus relating to the securities to be issued to Freenome’s stockholders. Additional information about the transaction is also expected to appear in a Current Report on Form 8-K filed by PCSC.
On this page, users can access PCSC’s historical and future SEC submissions, including registration statements, proxy materials and current reports that describe its SPAC structure, risk factors and the terms of its proposed business combination. AI-powered tools on the platform can assist in summarizing long-form documents, clarifying key sections in forms such as S-4 and 8-K, and highlighting information relevant to the evolution of PCSC’s capital structure and its transition to any combined company.
Perceptive Capital Solutions Corp reported that One Fin entities and David MacKnight each disclose beneficial ownership of 843,482 shares of Class A Ordinary Shares, representing 9.5% of the class.
The filing states the 9.5% figure was calculated using May 12, 2026 outstanding shares of 8,911,250 Class A Ordinary Shares, per the issuer's Form 10-Q filed on May 13, 2026. The reporting persons assert shared voting and dispositive power over the 843,482 shares and disclaim group beneficial ownership beyond their pecuniary interest.
Perceptive Capital Solutions Corp. (PCSC), a healthcare-focused SPAC, is asking shareholders to approve a one-year extension of its deadline to complete a business combination from June 13, 2026 to June 13, 2027. The extra time is intended to complete its previously announced merger with Freenome, although that deal is not guaranteed.
Holders of Class A ordinary shares can redeem for cash if the extension is approved, receiving their pro rata share of the trust account, which held about $92.9 million or roughly $10.78 per share as of May 1, 2026, versus a market price of $11.17. The sponsor and insiders, who own about 22.1% of the voting power, have waived redemption rights and intend to vote for the proposals.
If the extension fails and no deal closes by the current deadline, PCSC would redeem all public shares and liquidate. The proxy highlights risks including high potential redemptions, possible Nasdaq delisting if listing standards are not met, and regulatory uncertainties such as CFIUS and Investment Company Act scrutiny if the SPAC remains active longer.
Perceptive Capital Solutions Corp filing amends a Schedule 13G to report holdings by CRCM-related entities and Chun R. Ding. The amendment shows specific share counts and percent ownership in the issuer's Class A Ordinary Shares.
The filing lists 99,600 shares (1.1%) attributed to CRCM Institutional Master Fund (BVI), Ltd., and 116,245 shares (1.3%) attributed to CRCM LP / CRCM LLC and to Chun R. Ding. These percentages are calculated based on 8,911,250 Class A Ordinary Shares outstanding as of March 10, 2026, per the issuer's Form 10-K. The reporting persons disclaim beneficial ownership where stated.
Perceptive Capital Solutions Corp, a SPAC, reported a small net loss of $51,749 for the quarter ended March 31, 2026, compared with net income in the prior-year period. General and administrative expenses rose to $858,834 from $255,958, reflecting higher costs as it advances its business combination process.
Funds in the trust account grew to $92,679,503, mainly from interest on U.S. Treasury securities, while cash outside the trust was $567,179 with a working capital deficit of $2,205,508. The company has not begun operating a business and remains focused on completing its initial business combination.
The SPAC has a Business Combination Agreement with Freenome Holdings, Inc., targeting closing in the first half of 2026, supported by a committed PIPE financing of $240,000,000 at $10.00 per share. Its mandatory liquidation date is June 13, 2026, and management discloses substantial doubt about its ability to continue as a going concern unless it closes a transaction or secures an extension; a shareholder vote is being sought to extend the deadline to June 13, 2027.
Perceptive Capital Solutions Corp is asking shareholders to approve an amendment to its Memorandum and Articles of Association to extend the deadline to complete an initial business combination from June 13, 2026 to June 13, 2027 (the "Articles Extension") and to approve a conditional adjournment mechanism.
The proposal follows PCSC's December 5, 2025 business combination agreement with Freenome; the extension would permit additional time to consummate that transaction or another business combination. Public holders may redeem Class A ordinary shares for their pro rata share of the Trust Account if the Articles Extension is implemented. As of May 1, 2026, the Trust Account held approximately $92.9 million, implying a redemption price of approximately $10.78 per public share versus a Nasdaq closing price of $11.17 on that date. The Board, including Initial Shareholders holding ~22.1% of voting power, recommends voting FOR both the Extension Amendment Proposal and the Adjournment Proposal.
Perceptive Capital Solutions Corp. (PCSC) files a preliminary proxy statement and Form S-4 prospectus to effect a business combination with Freenome Holdings, Inc. The transaction contemplates domestication of PCSC to Delaware, two-step mergers, and issuance of up to 83,067,500 shares of New Freenome Common Stock.
The deal includes a PIPE Financing of 24,000,000 shares at $10.00 per share for aggregate gross proceeds of $240.0 million, conditional upon Nasdaq listing and satisfaction of closing conditions. Estimated redemption activity and sponsor/PIPE ownership percentages are disclosed; shareholders have pro rata redemption rights from the trust account.
Aberdeen Group plc and abrdn Inc. report a Schedule 13G declaring beneficial ownership of 578,565 shares of Perceptive Capital Solutions Corp Class A Ordinary Shares, representing 6.49% of the class as reported.
The filing lists shared voting and dispositive power over 578,565 shares (no sole power). The CUSIP is G70077105. The cover date shown is 04/01/2026 and the filing is signed on 04/27/2026. The submission notes Aberdeen Group plc as the parent and abrdn Inc. as an operating subsidiary holding these shares on behalf of underlying clients.
Freenome Holdings and Perceptive Capital Solutions Corp. (PCSC) disclosed communications about a proposed Business Combination. PCSC intends to file a registration statement on Form S-4 and will distribute preliminary and definitive proxy statements/prospectuses to PCSC shareholders and Freenome stockholders for voting on the transaction. The documents will include details about the securities to be issued and related matters; shareholders are urged to read the proxy statement/prospectus when available.
Perceptive Capital Solutions Corp. files its Annual Report detailing its structure as a healthcare-focused SPAC and a proposed business combination with Freenome Holdings, Inc. The company has no operating revenues and was formed to complete an initial business combination.
PCSC completed its IPO on June 13, 2024, selling 8,625,000 Class A ordinary shares at $10.00 per share and placing $86,250,000 in a trust account. As of December 31, 2025, $91,872,418 was held in the trust account for a future transaction.
The SPAC is sponsored by an affiliate of Perceptive Advisors, a life sciences investment firm with over $9.5 billion of regulatory assets under management as of December 31, 2025. PCSC targets life sciences and medical technology businesses, particularly in North America and Europe, and must complete a business combination by June 13, 2026 or return funds to public shareholders.
Perceptive Capital Solutions Corp. provided an update regarding the proposed business combination with Freenome Holdings, Inc. and disclosed that Freenome processed a batch of patient samples through initiation of its Early Access Program this quarter. The communication states the parties remain on track for 2026 milestones, including CRC v1 approval (mid-year), a CRC v2 final readout and sPMA submission, additional pipeline readouts (including Lung and P-MCD), and commercial launch objectives for multiple tests. The update notes a $240M PIPE that was raised pending SEC review and that the parties are "targeting the de-SPAC in the first half of the year." PCSC intends to file a Form S-4 registration statement and will distribute proxy/prospectus materials to shareholders when available.